Clorox reported Q2 FY26 results in line with expectations, with management reiterating full-year guidance and emphasizing a stronger back half. The call highlighted continued competitive pressures in trash bags and cat litter but noted sequential share improvement and a robust innovation pipeline. The acquisition of Gojo/Purell was framed as a key strategic move to expand health and hygiene leadership. Q2 FY26 results were largely in line with expectations; category growth flat, with sequential improvement in share performance.
Clorox reported Q2 FY26 results in line with expectations, with management reiterating full-year guidance and emphasizing a stronger back half. The call highlighted continued competitive pressures in trash bags and cat litter but noted sequential share improvement and a robust innovation pipeline. The acquisition of Gojo/Purell was framed as a key strategic move to expand health and hygiene leadership. Q2 FY26 results were largely in line with expectations; category growth flat, with sequential improvement in share performance.
Clorox reported Q2 FY26 results in line with expectations, with management reiterating full-year guidance and emphasizing a stronger back half. The call highlighted continued competitive pressures in trash bags and cat litter but noted sequential share improvement and a robust…
Q2 FY26 results were largely in line with expectations; category growth flat, with sequential improvement in share performance.
Management acknowledges challenges but expresses confidence in back-half plans and long-term strategy, balancing realistic caution with optimism.
Innovation pipeline is broad (e.g., Pure allergen platform, Glads Leak Guard, Litter relaunch) and is expected to drive improvement in Q3/Q4.
Category growth expected flat to up 1% in back half. Management acknowledges challenges but expresses confidence in back-half plans and long-term strategy, balancing realistic caution with optimism.
Management acknowledges challenges but expresses confidence in back-half plans and long-term strategy, balancing realistic caution with optimism.
“And so we're seeing the investments that we're putting in place working. I think as you maybe take a step back on the consumer... we are a growing share in the last week.”